Tag: FDA

Court Rules to Reinstate Significant Restrictions on Abortion Medication but Not to Revoke FDA Approval of the Drug

Mifepristone will remain available under current regulations due to an earlier U.S. Supreme Court order.

Appellate Court Rules to Reinstate Restrictions on Abortion Pill 

08.16.23 (PRESS RELEASE) — Today, the U.S. Court of Appeals for the Fifth Circuit largely upheld an unprecedented order from Judge Matthew Kacsmaryk threatening access to mifepristone—one of two drugs used in medication abortion. The federal appellate court ruled for the second time to reinstate burdensome restrictions on mifepristone from pre-2016, but not to revoke FDA […]

U.S. Repro Watch, May 17

North Carolina enacts a 12-week abortion ban, hearing on the medication abortion case, harms of abortion bans, and other top news on U.S. reproductive rights.

Center Files Lawsuit to Ensure Access to Abortion Drug in Three States

Lawsuit seeks to protect mifepristone access in Virginia, Montana, and Kansas in light of the drug’s legal uncertainty.

The Center and Movement Partners Urge Court to Block Unprecedented Ruling Rejecting FDA’s Approval of Abortion Drug

Amicus brief of more than 100 reproductive rights, health, and justice partners highlights the proven safety and efficacy of the drug, the ruling’s “immediate and life-threatening consequences,” and the court’s reliance on “debunked data.”  

Texas judge could end access to abortion medication mifepristone nationwide

In an interview with MSNBC, President and CEO Nancy Northup discusses the lawsuit filed against the FDA to remove an abortion medication in all 50 states.

Nationwide Threat to Medication Abortion

Anti-abortion advocates sue the FDA attempting to remove an abortion medication in all 50 states.